| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/31/2013 | US20130029349 Assays for the detection of microbes |
| 01/31/2013 | US20130029343 Multiwell strips |
| 01/31/2013 | US20130029337 Methods and uses involving genetic abnormalities at chromosome 12 |
| 01/31/2013 | US20130029335 Spinocerebellar ataxia type 8 and methods of detection |
| 01/31/2013 | US20130029327 Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof |
| 01/31/2013 | US20130029322 Anti-hpv e7 antibodies |
| 01/31/2013 | US20130029321 Sample processing device and method |
| 01/31/2013 | US20130029318 Microchips and Methods for Testing a Fluid Sample |
| 01/31/2013 | US20130028989 Materials and method for inhibiting replication protein a and uses thereof |
| 01/31/2013 | US20130028927 Method of diagnosing and treating melioidosis |
| 01/31/2013 | US20130028922 Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof |
| 01/31/2013 | US20130028914 Antibodies that Bind Tau Oligomers |
| 01/31/2013 | US20130028913 Antibody that binds to h-1 parvovirus |
| 01/31/2013 | US20130028910 Hmg1 antibody for treating inflammatory conditions |
| 01/31/2013 | US20130028902 Osteocalcin as a treatment for male reproductive disorders |
| 01/31/2013 | US20130028900 Methods and compositions for the generation and use of conformation-specific antibodies |
| 01/31/2013 | US20130028899 Treatment of cancer by inhibiting activity or expression of late sv-40 factor |
| 01/31/2013 | US20130028885 Methods to predict and prevent resistance to taxoid compounds |
| 01/31/2013 | US20130028863 Promyelocytic leukemia protein as a redox sensor |
| 01/31/2013 | US20130028856 Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions |
| 01/31/2013 | US20130028843 Kallikrein 7 modulators |
| 01/31/2013 | US20130026051 Biosensor |
| 01/31/2013 | DE102011109871A1 Vorrichtung und Verfahren zur Prüfung der Reinheit und der rheologischen Eigenschaften von Kunststoffschmelzen Apparatus and method for testing the purity and the rheological properties of polymer melts |
| 01/31/2013 | DE102011108764A1 Timber humidity measuring device, has housing forming measuring chamber and formed with housing wall for attachment at timber, where humidity sensor and temperature sensor are arranged in measuring chamber |
| 01/31/2013 | DE102011080947B3 Einzelanalyterfassung mittels magnetischer Durchflussmessung Einzelanalyterfassung by magnetic flow measurement |
| 01/31/2013 | DE102011079698A1 Micro-fluidic device for storing and mixing liquids e.g. water, in lab-on-chip system for environmental or medical analysis, has micro-fluidic channels storing liquid and including hydrophobic or super-hydrophobic surface on inside wall |
| 01/31/2013 | CA2843243A1 Estimating oil viscosity |
| 01/31/2013 | CA2843234A1 Method for screening induced pluripotent stem cells |
| 01/31/2013 | CA2843124A1 Nik inhibitors cell-based screening assay |
| 01/31/2013 | CA2842995A1 Method for detecting biomolecules |
| 01/31/2013 | CA2842875A1 Novel a2m fragments and applications thereof |
| 01/31/2013 | CA2842839A1 Ovarian markers of follicular maturity and uses thereof |
| 01/31/2013 | CA2842695A1 Templated islet cells and small islet cell clusters for diabetes treatment |
| 01/31/2013 | CA2842594A1 Method for determining the spatial and temporal distribution of the activity of a proteolytic enzyme in a heterogeneous system (variations), device for realizing same and method for diagnosing defects in the hemostatic system on the basis of a change in the spatial and temporal distribution of the activity of a proteolytic enzyme in a heterogeneous system |
| 01/31/2013 | CA2842443A1 Synthetic lethality and the treatment of cancer |
| 01/31/2013 | CA2842134A1 Device for measuring the free chloride content of a water |
| 01/31/2013 | CA2841976A1 A single-pad strip for an improved lateral flow assay and a test device using the same |
| 01/31/2013 | CA2841937A1 Deuterium free, stable isotope labeled 2-phenylethylamine hallucinogens and/or stimulants, methods of their preparation and their use |
| 01/31/2013 | CA2841915A1 Means and methods for diagnosing and monitoring heart failure in a subject |
| 01/31/2013 | CA2841308A1 Microstructured adhesion substrate for animal or human cells |
| 01/30/2013 | EP2551675A1 Deuterium free, stable isotope labeled 2-phenylethylamine hallucinogens and/or stimulants, methods fo their preparation and their use |
| 01/30/2013 | EP2551674A1 MT1-MMP substrates as biomarkers of inflammatory angiogenesis |
| 01/30/2013 | EP2551673A2 Methods and kits for the detection of cancer infiltration of the central nervous system |
| 01/30/2013 | EP2551672A1 Antibody-based arrays for detecting multiple signal transducers in rare circulating cells |
| 01/30/2013 | EP2551671A2 Immunoassay device with immuno-reference electrode |
| 01/30/2013 | EP2551670A1 NIK inhibitors cell-based assay |
| 01/30/2013 | EP2551669A1 System and method for tailoring food or beverage products to consumer requirements |
| 01/30/2013 | EP2551667A2 Method and apparatus for sensing ion concentrations in a fluid sample |
| 01/30/2013 | EP2551664A1 Measurement system |
| 01/30/2013 | EP2551352A1 Fluorescent probe for plasma cell identification and isolation, and plasma cell identification or isolation method using the probe |
| 01/30/2013 | EP2551343A1 Method for monitoring state of differentiation in stem cell |
| 01/30/2013 | EP2551282A2 Antibodies against CD38 for treatment of multiple myeloma |
| 01/30/2013 | EP2551087A1 Method for determining the quality of unlinked rubber mixtures and corresponding device |
| 01/30/2013 | EP2550976A2 Modulator compounds of the drug resistance in epithelial tumour cells |
| 01/30/2013 | EP2550972A1 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases |
| 01/30/2013 | EP2550969A1 Method of diagnosing allergy or hypersensitivity to opiates and to structurally related compounds. |
| 01/30/2013 | EP2550570A1 An arrangement and a method for ventilation of a space |
| 01/30/2013 | EP2550535A1 Hbf and a1m as early stage markers for preeclampsia |
| 01/30/2013 | EP2550534A1 Prognosis of oesophageal and gastro-oesophageal junctional cancer |
| 01/30/2013 | EP2550533A1 Early detection of recurrent breast cancer using metabolite profiling |
| 01/30/2013 | EP2550532A1 Method of supressing cancer, increasing weight loss and/or increasing insulin sensitivity |
| 01/30/2013 | EP2550531A1 Methods and apparatuses for predicting the effects of erythropoesis stimulating agents (esa), and for determining a dose to be administered |
| 01/30/2013 | EP2550530A1 Residual compensation for a biosensor |
| 01/30/2013 | EP2550529A1 Bioinformatic processes for determination of peptide binding |
| 01/30/2013 | EP2550527A1 Chemical and biological sensor using detection improvement agent vaporizers |
| 01/30/2013 | EP2550526A2 Device for deriving electrophysiological signals from cells |
| 01/30/2013 | EP2550524A1 Methods and systems for surface enhanced optical detection |
| 01/30/2013 | EP2550508A1 A system and a method relating to measuring humidity in a ventilated space |
| 01/30/2013 | EP2550371A1 Protein and gene biomarkers for rejection of organ transplants |
| 01/30/2013 | EP2550370A1 Mutations associated with cystic fibrosis |
| 01/30/2013 | EP2550352A1 Substrate, culture facility and culture method for biological cells |
| 01/30/2013 | EP2550338A1 Development of photostable near-ir cyanine dyes for in vivo imaging |
| 01/30/2013 | EP2550294A2 Prophylaxis of colorectal and gastrointestinal cancer |
| 01/30/2013 | EP2550289A2 Novel immunogens and methods for discovery and screening thereof |
| 01/30/2013 | EP2550147A1 Immunoassays, methods for carrying out immunoassays, immunoassay kits and method for manufacturing immunoassay kits |
| 01/30/2013 | EP2550105A1 Detection device for detecting analytes in liquid specimen |
| 01/30/2013 | EP2549925A1 Multimodal diagnostic technology for early stage cancer lesions |
| 01/30/2013 | EP2549858A2 Advanced egg breaking system |
| 01/30/2013 | CN202711435U Novel early-warning device for oxygen content of fishpond |
| 01/30/2013 | CN202711085U Novel ozone air cleaning device |
| 01/30/2013 | CN202710576U Test tube stand pushing mechanism |
| 01/30/2013 | CN202710575U Biomedical detection device |
| 01/30/2013 | CN202710573U Indoor quality control product reagent kit for transfusion compatibility detection |
| 01/30/2013 | CN202710572U Kit capable of rapidly detecting diethylstilbestrol |
| 01/30/2013 | CN202710571U Cortisol enzyme-linked immunosorbent assay kit |
| 01/30/2013 | CN202710570U Kit for fast detecting patulin |
| 01/30/2013 | CN202710569U Kit capable of rapidly detecting fumonisins |
| 01/30/2013 | CN202710568U Colloidal gold test paper strip and kit both capable of rapidly detecting egg allergen ovalbumin |
| 01/30/2013 | CN202710567U Colloidal gold test paper strip and kit both capable of rapidly detecting lincomycin |
| 01/30/2013 | CN202710566U Colloidal gold test strip and kit for fast detecting neomycin |
| 01/30/2013 | CN202710565U Kit for fast detecting semlcarbazide hydrochloride |
| 01/30/2013 | CN202710564U Kit for fast detecting vomitoxin |
| 01/30/2013 | CN202710563U Colloidal gold test strip and kit for fast detecting residual spiramycin |
| 01/30/2013 | CN202710562U Specific gamma-glutamyl transpeptidase (GGT) detection kit |
| 01/30/2013 | CN202710561U Biological chip for detecting pathogen indicator |
| 01/30/2013 | CN202710560U Kit for fast detecting Listeria monocytogenes |
| 01/30/2013 | CN202710559U Kit for quick detection of odontoglossum ringspot viruses |
| 01/30/2013 | CN202710558U Antibody releasing reaction sleeve |
| 01/30/2013 | CN202710557U Immune colloidal gold kit for detecting fluoroquinolone drug in dairy product |
| 01/30/2013 | CN202710556U Colloidal gold test strip and kit for fast detecting sulfadimidine residual |